CD274 and neoplasm: Patients receiving ONCOS‐102 treatment displayed PD‐L1 upregulation in melanoma cells,33 and the results showed that combinatorial ONCOS‐102 and anti‐PD‐L1 emerged an enhanced anti‐tumor efficacy.34